PART II. OTHER INFORMATION  



 Item 1.  



Legal Proceedings  



There are no pending or threatened legal proceedings against the Company believed to be material to the financial position or results of operations of the Company.  



 Item 1A.  



Risk Factors  





There have been no material updates to the risk factors previously disclosed in the Companys Annual Report on Form 10-K for the fiscal year ended January 31, 2019.  



 Item 2.  



Unregistered Sales of Equity Securities and Use of Proceeds  







 (a)  



Executives of the Company delivered 4,420 shares of the Companys common stock toward the satisfaction of taxes due with respect to vesting of restricted shares. The shares delivered were valued at a weighted-average market value of $26.29 per share and are included with treasury stock in the consolidated balance sheet. These transactions were not part of a publicly announced purchase plan or program.  



 (b)  



Executives of the Company delivered 9,917 shares of the Companys common stock toward the satisfaction of taxes due with respect to vesting of restricted shares. The shares delivered were valued at a weighted-average market value of $26.22 per share and are included with treasury stock in the consolidated balance sheet. These transactions were not part of a publicly announced purchase plan or program.  



 Item 6.  



Exhibits  







Table of Contents 



 32.2   Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002  







Management contract or compensatory plan or arrangement.  





Table of Contents 



SIGNATURES  



Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.  





